Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of ACYW135 Meningococcal Polysaccharide Vaccine
NCT02867319Phase 1Completed
- Sponsor
- Beijing Chaoyang District Center for Disease Control and Prevention
- Start
- Mar 2016
- Primary completion
- Jul 2016
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 1, open-label trial of A, C, Y, W135 meningococcal polysaccharide vaccine in meningococcal disease (3 arms), sponsored by Beijing Chaoyang District Center for Disease Control and Prevention. Primary endpoint: The rate of adverse reactions of ACYW135 meningococcal polysaccharide vaccine at 28 days. Started Mar 2016; status: completed.
02
Drugs
A, C, Y, W135 meningococcal polysaccharide vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT02867319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867319.